Multiple studies have reported myocarditis and pericarditis after the Pfizer-BioNTech coronavirus disease 2019 messenger ribonucleic acid vaccine. We describe male adolescent triplets who presented with myopericarditis within one week following vaccine administration.
Keywords: BNT162b2; COVID-19; SARS-CoV-2; myocarditis; pericarditis; vaccine.